BWVI Stock Overview
Blue Water Ventures International, Inc., through its subsidiary, Psycheceutical Inc., focuses on developing pharmaceutical products and technologies for mental health treatments.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Blue Water Ventures International, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.015 |
| 52 Week High | US$0.19 |
| 52 Week Low | US$0.011 |
| Beta | 0 |
| 1 Month Change | -53.13% |
| 3 Month Change | -71.15% |
| 1 Year Change | -91.43% |
| 3 Year Change | -83.33% |
| 5 Year Change | -81.66% |
| Change since IPO | -96.43% |
Recent News & Updates
Recent updates
Shareholder Returns
| BWVI | US Biotechs | US Market | |
|---|---|---|---|
| 7D | -4.2% | -4.2% | -3.7% |
| 1Y | -91.4% | -2.0% | 20.5% |
Return vs Industry: BWVI underperformed the US Biotechs industry which returned -1.7% over the past year.
Return vs Market: BWVI underperformed the US Market which returned 20.2% over the past year.
Price Volatility
| BWVI volatility | |
|---|---|
| BWVI Average Weekly Movement | 52.0% |
| Biotechs Industry Average Movement | 11.5% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: BWVI's share price has been volatile over the past 3 months.
Volatility Over Time: BWVI's weekly volatility has increased from 32% to 52% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | n/a | Neilank Jha | www.psycheceutical.com |
Blue Water Ventures International, Inc., through its subsidiary, Psycheceutical Inc., focuses on developing pharmaceutical products and technologies for mental health treatments. The company was incorporated in 2006 and is based in Fort Lauderdale, Florida.
Blue Water Ventures International, Inc. Fundamentals Summary
| BWVI fundamental statistics | |
|---|---|
| Market cap | US$14.28m |
| Earnings (TTM) | US$0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs BWVI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BWVI income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$0 |
| Earnings | US$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did BWVI perform over the long term?
See historical performance and comparison